Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT vs RT+TMZ in High-risk Low-grade Gliomas
NCT04316039Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2018
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in glioma, sponsored by West China Hospital of Sichuan University. Started Apr 2018; status: recruiting.
02
Drugs
temozolomide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT04316039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04316039.